QSAR study on N- (Aryl)-4-(Azolylethyl) Thiazole-5-Carboxamides: Novel Potent Inhibitors of VEGF Receptors I and II

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|5|5|455-461

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.5, Iss.5, 2009-09, pp. : 455-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QSAR Study on Hetaryl Imidazoles: A Novel Dual Inhibitor of VEGF Receptors I and II

By  

Medicinal Chemistry, Vol. 6, Iss. 1, 2010-01 ,pp. : 24-29

Bentham Science Publishers

Access to resources Recommend Favorite

3D QSAR Analysis of 2-(Substituted Aryl)-Thiazolidine-4-Carboxamides as Potent Antitubercular Agents

By  

Current Computer - Aided Drug Design, Vol. 10, Iss. 3, 2015-03 ,pp. : 274-281

Bentham Science Publishers

Access to resources Recommend Favorite

In-silico Designing of Novel Camptothecin Analogues as Potent Inhibitors of Topoisomerase I: A Molecular Docking, QSAR, and ADME-T Study

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-10 ,pp. : 859-868

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Aglycones of Steroidal Glycoalkaloids as Potent Tyrosine Kinase Inhibitors: Role in VEGF and EGF Receptors Targeted Angiogenesis

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 3, 2011-03 ,pp. : 205-215

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR and Molecular Docking Studies on a Series of 1-Amino-5H-pyrido [4, 3-b]indol-4-carboxamides Acting as Janus Kinase 2 (JAK2) Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 15, Iss. 2, 2018-01 ,pp. : 169-180

Bentham Science Publishers

Access to resources Recommend Favorite